TherapeuticsMD
TXMD
TXMD
87 hedge funds and large institutions have $384M invested in TherapeuticsMD in 2014 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 32 increasing their positions, 26 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
87
Holders Change
+4
Holders Change %
+4.82%
% of All Funds
2.5%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
32
Reduced
26
Closed
17
Calls
$273K
Puts
$11K
Net Calls
+$262K
Net Calls Change
+$195K
Top Buyers
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$24.5M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$15.2M |
| 3 |
JG
Jefferies Group
New York
|
-$5.27M |
| 4 |
CCM
Cadian Capital Management
New York
|
-$3.16M |
| 5 |
BC
Broadfin Capital
New York
|
-$2.9M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Neuberger Berman Group
New York
| – | -$118K | -375 | Closed |
|
|
MC
102
Menta Capital
San Francisco,
California
| – | -$109K | -346 | Closed |
|
|
PA
103
Perceptive Advisors
New York
| – | -$44K | -140 | Closed |
|